Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Residual Tumor Cells That Drive Disease Relapse after Chemotherapy Do Not Have Enhanced Tumor Initiating Capacity

  • Ganapati V. Hegde,

    Affiliation Department of Discovery Oncology, Genentech, Inc., South San Francisco, California, United States of America

  • Cecile de la Cruz,

    Affiliation Department of Discovery Oncology, Genentech, Inc., South San Francisco, California, United States of America

  • Jeffrey Eastham-Anderson,

    Affiliation Department of Pathology, Genentech, Inc., South San Francisco, California, United States of America

  • Yanyan Zheng,

    Affiliation Cancer Biology Program, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America

  • E. Alejandro Sweet-Cordero,

    Affiliation Cancer Biology Program, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America

  • Erica L. Jackson

    ericaj@gene.com

    Affiliation Department of Discovery Oncology, Genentech, Inc., South San Francisco, California, United States of America

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.